SE7811323L - Nya kinazolinderivat med terapeutisk aktivitet - Google Patents
Nya kinazolinderivat med terapeutisk aktivitetInfo
- Publication number
- SE7811323L SE7811323L SE7811323A SE7811323A SE7811323L SE 7811323 L SE7811323 L SE 7811323L SE 7811323 A SE7811323 A SE 7811323A SE 7811323 A SE7811323 A SE 7811323A SE 7811323 L SE7811323 L SE 7811323L
- Authority
- SE
- Sweden
- Prior art keywords
- new
- therapeutic activity
- chinazoline derivatives
- chinazoline
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/40—Acylated substituent nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
- C07D211/28—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms to which a second hetero atom is attached
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/42—Radicals substituted by singly-bound nitrogen atoms having hetero atoms attached to the substituent nitrogen atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Cardiology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB4566977 | 1977-11-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE7811323L true SE7811323L (sv) | 1979-05-04 |
Family
ID=10438111
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7811323A SE7811323L (sv) | 1977-11-03 | 1978-11-01 | Nya kinazolinderivat med terapeutisk aktivitet |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US4188391A (fr) |
| JP (1) | JPS5498786A (fr) |
| AR (2) | AR221851A1 (fr) |
| AT (1) | AT366043B (fr) |
| AU (1) | AU506317B2 (fr) |
| BE (1) | BE871769A (fr) |
| CA (1) | CA1086735A (fr) |
| CH (1) | CH637130A5 (fr) |
| DE (1) | DE2847622A1 (fr) |
| DK (1) | DK488078A (fr) |
| ES (2) | ES474763A1 (fr) |
| FI (1) | FI63934C (fr) |
| FR (1) | FR2407926A1 (fr) |
| HK (1) | HK94184A (fr) |
| IE (1) | IE47996B1 (fr) |
| IL (1) | IL55845A (fr) |
| IT (1) | IT1101287B (fr) |
| KE (1) | KE3351A (fr) |
| LU (1) | LU80461A1 (fr) |
| MY (1) | MY8500284A (fr) |
| NL (1) | NL174144C (fr) |
| PH (1) | PH14693A (fr) |
| PT (1) | PT68733A (fr) |
| SE (1) | SE7811323L (fr) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4489075A (en) * | 1982-05-15 | 1984-12-18 | Pfizer Inc. | Cyclic sulfonamidoalkyl substituted 4-piperidinoquinazoline cardiac stimulants |
| JPS61215389A (ja) * | 1985-03-20 | 1986-09-25 | Kyowa Hakko Kogyo Co Ltd | キナゾリン誘導体およびそれを含有する強心剤 |
| WO1995007267A1 (fr) * | 1993-09-10 | 1995-03-16 | Eisai Co., Ltd. | Compose de quinazoline |
| AU3784997A (en) * | 1996-08-09 | 1998-03-06 | Eisai Co. Ltd. | Benzopiperidine derivatives |
| EP2258358A3 (fr) | 2005-08-26 | 2011-09-07 | Braincells, Inc. | Neurogenèse avec un inhibiteur de l'acetylcholinestérase |
| US7678363B2 (en) | 2005-08-26 | 2010-03-16 | Braincells Inc | Methods of treating psychiatric conditions comprising administration of muscarinic agents in combination with SSRIs |
| EP1940389A2 (fr) | 2005-10-21 | 2008-07-09 | Braincells, Inc. | Modulation de la neurogenese par inhibition de la pde |
| US20070112017A1 (en) | 2005-10-31 | 2007-05-17 | Braincells, Inc. | Gaba receptor mediated modulation of neurogenesis |
| EP1991212A1 (fr) * | 2006-03-08 | 2008-11-19 | Braincells, Inc. | Modulation de neurogenèse par des agents nootropes |
| US20100216734A1 (en) * | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
| MX2008014320A (es) | 2006-05-09 | 2009-03-25 | Braincells Inc | Neurogenesis mediada por el receptor de 5-hidroxitriptamina. |
| US20100009983A1 (en) * | 2006-05-09 | 2010-01-14 | Braincells, Inc. | 5 ht receptor mediated neurogenesis |
| AU2007249399A1 (en) | 2006-05-09 | 2007-11-22 | Braincells, Inc. | Neurogenesis by modulating angiotensin |
| JP2010502722A (ja) * | 2006-09-08 | 2010-01-28 | ブレインセルス，インコーポレイティド | ４−アシルアミノピリジン誘導体を含む組み合わせ |
| AU2007299920A1 (en) * | 2006-09-19 | 2008-03-27 | Braincells, Inc. | PPAR Mediated Modulation of Neurogenesis |
| US20100184806A1 (en) | 2006-09-19 | 2010-07-22 | Braincells, Inc. | Modulation of neurogenesis by ppar agents |
| AU2007307995B2 (en) * | 2006-10-06 | 2013-01-17 | Bausch & Lomb Incorporated | Quinolone carboxylic acids, derivatives thereof, processes for its preparation and its use as antibacterial agents |
| US7632944B2 (en) * | 2007-01-24 | 2009-12-15 | Bausch & Lomb Incorporated | Quinolone carboxylic acids, derivatives thereof, and methods of making and using same |
| WO2010099217A1 (fr) | 2009-02-25 | 2010-09-02 | Braincells, Inc. | Modulation de neurogenèse à l'aide de combinaisons de d-cyclosérine |
| US20150119399A1 (en) | 2012-01-10 | 2015-04-30 | President And Fellows Of Harvard College | Beta-cell replication promoting compounds and methods of their use |
| EP3941459A4 (fr) * | 2019-03-19 | 2022-11-30 | Stingray Therapeutics, Inc. | Composés de quinoléine et de quinazoline et leurs procédés d'utilisation |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1199768A (en) * | 1966-10-31 | 1970-07-22 | Pfizer & Co C | Nitrogen Heterocycles and process for their preparation |
| US3812127A (en) * | 1966-10-31 | 1974-05-21 | Pfizer | 4-(quinolin-4-yl)piperazine-1-carboxylic acid esters |
| US3517005A (en) * | 1967-10-26 | 1970-06-23 | Pfizer & Co C | Certain 2- and 4-substituted quinazolines |
| GB1460389A (en) * | 1974-07-25 | 1977-01-06 | Pfizer Ltd | 4-substituted quinazoline cardiac stimulants |
-
1978
- 1978-10-24 CA CA314,062A patent/CA1086735A/fr not_active Expired
- 1978-10-26 US US05/954,931 patent/US4188391A/en not_active Expired - Lifetime
- 1978-10-30 PH PH21751A patent/PH14693A/en unknown
- 1978-10-31 LU LU80461A patent/LU80461A1/fr unknown
- 1978-11-01 CH CH1125378A patent/CH637130A5/de not_active IP Right Cessation
- 1978-11-01 AR AR274310A patent/AR221851A1/es active
- 1978-11-01 NL NLAANVRAGE7810865,A patent/NL174144C/xx not_active IP Right Cessation
- 1978-11-01 SE SE7811323A patent/SE7811323L/xx unknown
- 1978-11-01 FI FI783325A patent/FI63934C/fi not_active IP Right Cessation
- 1978-11-01 DK DK488078A patent/DK488078A/da not_active Application Discontinuation
- 1978-11-01 IL IL55845A patent/IL55845A/xx unknown
- 1978-11-02 AU AU41277/78A patent/AU506317B2/en not_active Expired
- 1978-11-02 FR FR7831062A patent/FR2407926A1/fr active Granted
- 1978-11-02 AT AT0783878A patent/AT366043B/de not_active IP Right Cessation
- 1978-11-02 PT PT68733A patent/PT68733A/pt unknown
- 1978-11-02 JP JP13569678A patent/JPS5498786A/ja active Granted
- 1978-11-02 IE IE2165/78A patent/IE47996B1/en unknown
- 1978-11-02 IT IT29368/78A patent/IT1101287B/it active
- 1978-11-02 ES ES474763A patent/ES474763A1/es not_active Expired
- 1978-11-02 DE DE19782847622 patent/DE2847622A1/de not_active Ceased
- 1978-11-03 BE BE191542A patent/BE871769A/fr not_active IP Right Cessation
-
1979
- 1979-04-27 ES ES480053A patent/ES480053A1/es not_active Expired
- 1979-11-01 AR AR278733A patent/AR221251A1/es active
-
1983
- 1983-11-21 KE KE3351A patent/KE3351A/xx unknown
-
1984
- 1984-11-29 HK HK941/84A patent/HK94184A/xx unknown
-
1985
- 1985-12-30 MY MY284/85A patent/MY8500284A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BE871769A (fr) | 1979-05-03 |
| IL55845A0 (en) | 1979-01-31 |
| IE47996B1 (en) | 1984-08-22 |
| LU80461A1 (fr) | 1980-05-07 |
| FR2407926B1 (fr) | 1982-11-12 |
| IT1101287B (it) | 1985-09-28 |
| US4188391A (en) | 1980-02-12 |
| AR221851A1 (es) | 1981-03-31 |
| PH14693A (en) | 1981-11-10 |
| AT366043B (de) | 1982-03-10 |
| CH637130A5 (de) | 1983-07-15 |
| FI783325A (fi) | 1979-05-04 |
| HK94184A (en) | 1984-12-07 |
| IT7829368A0 (it) | 1978-11-02 |
| AR221251A1 (es) | 1981-01-15 |
| NL174144C (nl) | 1984-05-01 |
| IL55845A (en) | 1982-07-30 |
| ES480053A1 (es) | 1980-07-16 |
| NL174144B (nl) | 1983-12-01 |
| NL7810865A (nl) | 1979-05-07 |
| CA1086735A (fr) | 1980-09-30 |
| ES474763A1 (es) | 1980-12-16 |
| AU4127778A (en) | 1979-05-17 |
| ATA783878A (de) | 1981-07-15 |
| PT68733A (en) | 1978-12-01 |
| MY8500284A (en) | 1985-12-31 |
| FR2407926A1 (fr) | 1979-06-01 |
| JPS566428B2 (fr) | 1981-02-10 |
| DK488078A (da) | 1979-05-04 |
| AU506317B2 (en) | 1979-12-20 |
| FI63934C (fi) | 1983-09-12 |
| JPS5498786A (en) | 1979-08-03 |
| KE3351A (en) | 1983-12-16 |
| DE2847622A1 (de) | 1979-05-31 |
| FI63934B (fi) | 1983-05-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE7806710L (sv) | Nya karbostyrilderivat | |
| SE7811323L (sv) | Nya kinazolinderivat med terapeutisk aktivitet | |
| SE7810613L (sv) | Nya fenyletanolderivat | |
| FI781613A (fi) | Terapeutiska hydantoinfoereningar | |
| FI781614A (fi) | Terapeutiska aemnen | |
| FI781753A (fi) | Nya ftalazinderivat | |
| SE7802867L (sv) | Nya 4-acylamino-fenyl-etanolaminer | |
| FI781032A (fi) | Plastroer med laongsriktade kanaler i vaeggen | |
| SE7812268L (sv) | Fenylglycinderivat med terapeutisk verkan | |
| FI783396A (fi) | Kroppsnaera plagg foer hoeg aktivitet | |
| SE7807642L (sv) | Nya 1-acyl-2-cyanaziridiner | |
| SE7811322L (sv) | Nya derivat av ftalazin med terapeutisk aktivitet | |
| FI780239A (fi) | Med boejliga tryckplattor foersedd formcylinder foer rotationstryckmaskiner | |
| FI54629C (fi) | Foerfarande i en med en genomstroemningstork foersedd tissuepappersmaskin | |
| SE7809373L (sv) | Farmaceutiskt anvendbara 5-hydroxi-1h-imidazol-4-karboxamidderivat | |
| SE7811457L (sv) | Nya kinolylguanidinderivat | |
| SE7800739L (sv) | Nya aminoalkoxifenylderivat | |
| FI782909A (fi) | Nya 7-azabenzimidazoler med basiska sidokedjor | |
| BE870634A (fr) | Agents therapeutiques antiallergiques | |
| SE7808018L (sv) | Nya imidazo-isokinolin-dioner | |
| DK35978A (da) | Furanderivater med fungcid aktivitet | |
| FI780350A (fi) | Nya terapeutiska medel | |
| FI782451A (fi) | Tretrycksstyrventil i en indirekt fungerande tryckluftsbroms med accelerationsventil | |
| SE7804318L (sv) | Nya naftyridiner | |
| FI781510A (fi) | Katodstraoleroer med minskade spaenningar i en med slitsformiga oeppningar foersedd haolskiva |